Lumibird
18.65
15-9月-25 08:29:50
15 分の遅延
株式
+0.45
+2.47%
本日の幅
18.25 - 19.00
ISIN
FR0000038242
ソース
Cboe
-
LUMIBIRD PHOTONICS SWEDEN SECURES MAJOR NAVAL CONTRACT FOR VIDAR RANGEFINDERS WITH SAAB AND DALO
24 6 2025 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR SKYRANGER 30
12 5 2025 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: REVENUE GROWTH OF+ 12.4% IN THE 1st QUARTER
28 4 2025 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2025
21 3 2025 09:45:00 提供 Nasdaq GlobeNewswire
-
11 3 2025 09:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: 2024 SALES AT €207.1M (+1.7% -REPORTED)
27 1 2025 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA
24 1 2025 08:45:00 提供 Nasdaq GlobeNewswire
-
Lumibird : nombre de droits de vote et d'actions au 30 novembre 2024
09 12 2024 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION
26 11 2024 23:00:00 提供 Nasdaq GlobeNewswire
-
21 10 2024 08:55:15 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M
15 10 2024 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: FIRST-HALF RESULTS FOR 2024 UP IN THE MEDICAL DIVISION, LOWER IN THE PHOTONICS DIVISION
24 9 2024 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD RECEIVES NEW ORDERS FROM THALES
24 7 2024 08:35:00 提供 Nasdaq GlobeNewswire
-
22 7 2024 08:50:17 提供 Nasdaq GlobeNewswire
-
LUMIBIRD PRESENTS ITS NEW STRATEGIC PLAN
22 5 2024 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE
02 5 2024 22:30:00 提供 Nasdaq GlobeNewswire
-
05 4 2024 08:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2024
25 3 2024 09:45:00 提供 Nasdaq GlobeNewswire
-
12 3 2024 09:45:00 提供 Nasdaq GlobeNewswire
-
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90
29 2 2024 08:45:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >